ArticleFrontiers in oncology2022

Gemcitabine Plus Anlotinib Is Effective and Safe Compared to Gemcitabine Plus Docetaxel in Advanced Soft Tissue Sarcoma.

Zhiyong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.